Sign up today
for an exclusive discount along with our 30-day GUARANTEE — Love us or leave, with your money back! Click here
to become a part of our growing community and learn how to stop gambling with your investments. We will teach you to BE THE HOUSE — Not the Gambler!Click here
to see some testimonials from our members!
Courtesy of Benzinga.
Sequenom, Inc. (NASDAQ: SQNM) yesterday announced that it has filed a motion for preliminary injunction against Aria Diagnostics to stop Aria from making, using, selling or offering for sale, importing or exporting, infringing tests for detecting fetal chromosomal aneuploidy, such as Aria’s Harmony Prenatal Test™, pending the ultimate resolution of the litigation.
Sequenom’s request for preliminary injunction follows the lawsuit filed on January 24, 2012, in the United States District Court for the Southern District of California, which alleges that Aria infringes U.S. Patent No. 6,258,540. Sequenom is requesting that the district court quickly intervene to stop Aria Diagnostics’ continued infringement of the ’540 patent.
(c) 2011 Benzinga.com. All rights reserved. This material may not be published in its entirety or redistributed without the approval of Benzinga.
For more Benzinga, visit Benzinga Professional Service, Value Investor, and Stocks Under $5.
Do you know someone
who would benefit from this
information? We can send your friend a strictly
confidential, one-time email telling them about this
information. Your privacy and your friend's privacy is
your business... no spam! Click here
and tell a friend!